Published 2015 | Version v1
Miscellaneous

AGuIX: a new class of multimodal ultra small gadolinium based nanoparticles for theranostic applications

  • 1. UMR 5306, ILM, Villeurbanne (France)
  • 2. INSERM, CRI, U823, Institut Albert Bonniot, Grenoble (France)
  • 3. Nano-H SAS, Saint-Quentin Fallavier (France)
  • 4. UTINAM, UMR 6213, Besancon (France)
  • 5. ESRF, ID 17 Biomedical Beamline, Grenoble (France)
  • 6. UMR 6213, MATEIS, Villeurbanne (France)

Description

Full text of publication follows. A new type of sub-5-nanometer ultra small gadolinium nano-probe has recently been developed by our team for biomedical applications. The AGuIX nanoparticles are composed of a polysiloxane matrix and surrounded by gadolinium chelates covalently grafted at the surface of the inorganic matrix [Ref.1]. They have been injected in healthy animals, they are eliminated by the kidneys and can be detected by four complementary imaging techniques (MRI, scintigraphy, optical imaging and X Ray tomography) [Ref.2]. Despite their small sizes, the nanoparticles are also concentrated in the tumors by enhanced permeability and retention (EPR) effect. The grafting of cRGDfK on the nanoparticles has been performed thanks to classical carbodiimide chemistry. The grafted nanoparticles present a high affinity (shown by flow cytometry and fluorescence microscopy) for cells expressing αvβ3 integrins in comparison with the same nanoparticles grafted with cRADfK as negative controls. The grafted nanoparticles were also injected in gliosarcoma tumor bearing mice and a higher signal in fluorescence was observed for cRGDfK grafted nanoparticles. Due to the presence of gadolinium (a high Z element), the AGuIX nanoparticles can also be used as radiosensitizer. A high radiosensitizing effect has been observed in vitro using different types of irradiation on radioresistant cells [Ref.3]. Finally the nanoparticles have been injected in 9L gliosarcoma bearing rats, the nanoparticles have been monitored by MRI to determine the best moment for irradiation (i. e. the higher concentration of nanoparticles in the tumor with the lowest concentration in the surrounding healthy tissue). The irradiation by MRT lead to a huge increase of the lifespan of the tumor bearing rats. References: [1] A. Mignot et al. Chem. Eur. J., 2013, DOI: 10.1002/chem.201203003; [2] F. Lux et al., Angew. Chem. Int. Ed., 2011, 123, 12507-12511; [3] P. Mowat et al., J. Nanosci. Nanotechnol., 2011, 11, 7833-7839; [4] G. Le Duc et al., ACS Nano, 2011, 5, 9566. (authors)

Part of:
WIPR 2013 - Radiopharmaceuticals: from research to industry - Book of abstracts

Additional details

Publishing Information

Imprint Title
WIPR 2013 - Radiopharmaceuticals: from research to industry - Book of abstracts
Imprint Pagination
171 p.
Journal Page Range
p. 85
Report number
INIS-FR--16-0086

Conference

Title
Radiopharmaceuticals - from research to industry
Acronym
WIPR 2013
Dates
9-12 Jul 2013
Place
Nantes (France)

INIS

Country of Publication
France
Country of Input or Organization
France
INIS RN
47017783
Subject category
S60: APPLIED LIFE SCIENCES; S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Conference, Non-conventional Literature
Descriptors DEI
BIOASSAY; CARRIERS; GADOLINIUM ISOTOPES; GLIOMAS; NANOPARTICLES; RADIOTHERAPY; RATS; SILOXANES
Descriptors DEC
ANIMALS; DISEASES; ISOTOPES; MAMMALS; MEDICINE; NEOPLASMS; NERVOUS SYSTEM DISEASES; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; ORGANIC SILICON COMPOUNDS; PARTICLES; RADIOLOGY; RODENTS; THERAPY; VERTEBRATES

Optional Information

Notes
3 refs.